Evidence map›Paper›PMID 25528158›Full record

ArticleBMC biology2014

Peripheral residence of naïve CD4 T cells induces MHC class II-dependent alterations in phenotype and function.

Sanket Rane, Rituparna Das, Vidya Ranganathan, Savit Prabhu, Arundhoti Das, Hamid Mattoo, Jeannine Marie Durdik, Anna George, Satyajit Rath, Vineeta Bal

Open access · goldAbstract read
In one paragraph

Article in BMC biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 3 countries.

Sanket RaneNational Institute of Immunology, New Delhi, 110067, India. sanketrn@nii.ac.in.
Rituparna DasNational Institute of Immunology, New Delhi, 110067, India. rituparna.das@yale.edu.
Vidya RanganathanNational Institute of Immunology, New Delhi, 110067, India. vrangana@uhnresearch.ca.
Savit PrabhuNational Institute of Immunology, New Delhi, 110067, India. savit@thsti.res.in.
Arundhoti DasNational Institute of Immunology, New Delhi, 110067, India. arundhoti@nii.ac.in.
Hamid MattooNational Institute of Immunology, New Delhi, 110067, India. mattoo.hamid@mgh.harvard.edu.
Jeannine Marie DurdikDepartment of Biological Sciences, University of Arkansas, Fayetteville, Arkansas, USA. jdurdik@uark.edu.
Anna GeorgeNational Institute of Immunology, New Delhi, 110067, India. anna@nii.res.in.
Satyajit RathNational Institute of Immunology, New Delhi, 110067, India. satyajit@nii.res.in.
Vineeta BalNational Institute of Immunology, New Delhi, 110067, India. vineeta@nii.res.in.
National Institute of Immunology · INUniversity of Arkansas at Fayetteville · US

Funding

Pharmacological vaccine adjuvants: analysis of immune responses to vaccinesR03AI070312 · NIAID · UNIVERSITY OF ARKANSAS AT FAYETTEVILLE · PI DURDIK, JEANNINE M. · 2009 to 2010
$142k
NIAID NIH HHS R03 AI070312NIAID NIH HHS R03AI070312-01A2
6 · The paper itself

Abstract

backgroundAs individual naïve CD4 T lymphocytes circulate in the body after emerging from the thymus, they are likely to have individually varying microenvironmental interactions even in the absence of stimulation via specific target recognition. It is not clear if these interactions result in alterations in their activation, survival and effector programming. Naïve CD4 T cells show unimodal distribution for many phenotypic properties, suggesting that the variation is caused by intrinsic stochasticity, although underlying variation due to subsets created by different histories of microenvironmental interactions remains possible. To explore this possibility, we began examining the phenotype and functionality of naïve CD4 T cells differing in a basic unimodally distributed property, the CD4 levels, as well as the causal origin of these differences.

resultsWe examined separated CD4hi and CD4lo subsets of mouse naïve CD4 cells. CD4lo cells were smaller with higher CD5 levels and lower levels of the dual-specific phosphatase (DUSP)6-suppressing micro-RNA miR181a, and responded poorly with more Th2-skewed outcomes. Human naïve CD4lo and CD4hi cells showed similar differences. Naïve CD4lo and CD4hi subsets of thymic single-positive CD4 T cells did not show differences whereas peripheral naïve CD4lo and CD4hi subsets of T cell receptor (TCR)-transgenic T cells did. Adoptive transfer-mediated parking of naïve CD4 cells in vivo lowered CD4 levels, increased CD5 and reactive oxygen species (ROS) levels and induced hyporesponsiveness in them, dependent, at least in part, on availability of major histocompatibility complex class II (MHCII) molecules. ROS scavenging or DUSP inhibition ameliorated hyporesponsiveness. Naïve CD4 cells from aged mice showed lower CD4 levels and cell sizes, higher CD5 levels, and hyporesponsiveness and Th2-skewing reversed by DUSP inhibition.

conclusionsOur data show that, underlying a unimodally distributed property, the CD4 level, there are subsets of naïve CD4 cells that vary in the time spent in the periphery receiving MHCII-mediated signals and show resultant alteration of phenotype and functionality via ROS and DUSP activity. Our findings also suggest the feasibility of potential pharmacological interventions for improved CD4 T cell responses during vaccination of older people via either anti-oxidant or DUSP inhibitor small molecules.

Indexed as

PhenotypeAdultAnimalsCD4-Positive T-LymphocytesCells, CulturedDual Specificity Phosphatase 6Feasibility StudiesFemaleHistocompatibility Antigens Class IIHumansLeukocytes, MononuclearMaleMiceMice, Inbred BALB CMice, Inbred C57BLMice, TransgenicDual Specificity Phosphatase 6DUSP6 protein, humanDusp6 protein, mouseHistocompatibility Antigens Class IIMicroRNAsMirn142 microRNA, mousemirn181 microRNA, mouseReactive Oxygen SpeciesReceptors, Antigen, T-Cell

Identifiers

PMID25528158
PMCPMC4306244
OpenAlexW1969390020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.